- Report
- November 2023
- 112 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- November 2023
- 78 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Book
- October 2012
- 1570 Pages
The Cholera Vaccine market is a subset of the larger Vaccines market. Cholera is an acute diarrheal infection caused by the bacterium Vibrio cholerae. Vaccines are the most effective way to prevent cholera, and the World Health Organization recommends that all people at risk of cholera should be vaccinated. The Cholera Vaccine market is composed of a variety of products, including oral and injectable vaccines. Oral vaccines are typically administered in two doses, while injectable vaccines are administered in a single dose.
The Cholera Vaccine market is highly competitive, with a number of companies offering products. These include Sanofi Pasteur, GlaxoSmithKline, Merck, Pfizer, and Emergent BioSolutions. Each company offers a range of products, including both oral and injectable vaccines. Additionally, some companies have developed combination vaccines that protect against multiple diseases, including cholera. Show Less Read more